1. Adamski, J., Godman, B., Ofierska-Sujkowska, G., Osinska, B., Herholz, H., Wendykowska, K., et al. (2010). Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Services Research,10, 153.
2. Aday, L. A., & Andersen, R. (1974). A framework for the study of access to medical care. Health Services Research,9(3), 208–220.
3. Alpern, J. D., Stauffer, W. M., & Kesselheim, A. S. (2014). High-cost generic drugs: Implications for patients and policymakers. New England Journal of Medicine,371(20), 1859–1862.
4. Association of the British Pharmaceutical Industry. (2014). Understanding the 2014 pharmaceutical price regulation scheme. London, UK.
5. Buchanan, A. E. (1984). The right to a decent minimum of health care. Philosophy and Public Affairs,13(1), 55–78.